Trial Profile
A retrospective analysis to evaluate the safety and efficacy of sofosbuvir and ledipasvir in renal transplant patients with chronic HCV infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 04 Oct 2016 New trial record